What is the ticker symbol for Inventiva S.A.?

Inventiva S.A. trades under the ticker IVA on NASDAQ.

What sector does Inventiva S.A. operate in?

Inventiva S.A. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IVA in a portfolio?

PortView shows IVA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Inventiva S.A. (IVA) Stock Analysis

NASDAQHealthcareBiotechnology

$4.83+1.15%

1-year price historyRange $3.41 – $7.15

52-week range$4.83

$3.35$7.98

What Inventiva S.A. does

Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases. The company's most advanced experimental drug is Lanifibranor, which has successfully completed Phase IIb clinical trials for the treatment of NASH. Inventiva is also progressing with Odiparcil, an asset that has finished its Phase IIa clinical studies for addressing the MPS VI subtype disease. Beyond these lead candidates, Inventiva maintains a robust pipeline of earlier-stage research and development programs, notably in oncology and other therapeutic areas. The company has also established important strategic alliances, including a partnership with AbbVie focused on treatments for autoimmune diseases, and a collaboration with Boehringer Ingelheim International GmbH aimed at discovering novel therapies for idiopathic pulmonary fibrosis. Inventiva S.A. was established in 2011 and is headquartered in Daix, France.

Key metrics

Market cap

$250.81M

P/E (TTM)

-1.63

EPS (TTM)

$-2.96

Beta

0.91

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$4.42

200-day avg

$5.06

52-week high

$7.98

52-week low

$3.35

CEO

Andrew Obenshain

ETFs linked to IVA

Broad-market and Healthcare sector ETFs an investor holding Inventiva S.A. is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IVA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IVA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Inventiva S.A.?: Inventiva S.A. trades under the ticker IVA on NASDAQ.
Which exchange is IVA listed on?: IVA is listed on NASDAQ.
What sector does Inventiva S.A. operate in?: Inventiva S.A. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IVA in a portfolio?: PortView shows IVA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.